Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
Clinico-biological Data Collection Study of Metastatic Breast Cancer (EPICURE_SEIN)

RATIONALE : Currently, the mechanisms associated with the response or resistance to treatment are poorly understood and are multifactorial. These mechanisms involve clinical and biological factors associated with the host and the tumor and possibly the patient's psycho-social environment. PURPOSE : This trial will assess the use of a prospective …

metastasis
progesterone
stage iv breast cancer
progesterone receptor
erbb2
  • 1 views
  • 04 Oct, 2022
  • 2 locations
Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery

This phase II trial studies whether intermittent fasting works to improve outcomes in patients with stage I-III breast cancer receiving chemotherapy before surgery (neoadjuvant) with a body mass index >= 25. Intermittent fasting has been shown to elicit similar metabolic changes as calorie restriction such as reduction in blood glucose …

cancer
body mass index
carcinoma in situ
breast carcinoma
erbb2
  • 0 views
  • 04 Oct, 2022
  • 1 location
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

To investigate the efficacy of albumin-bound paclitaxel combined with carboplatin versus epirubicin combined with docetaxel as neoadjuvant therapy for triple-negative breast cancer.

docetaxel
progesterone
paclitaxel
erbb2
progesterone receptor
  • 0 views
  • 31 Jul, 2021
  • 7 locations
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions

TCRA is an important surgical method to restore normal menstrual cycle and improve the outcome of pregnancy.However, postoperative intrauterine adhesion, uterine cavity deformation and difficulty in normal intimal growth seriously affect the efficacy of surgery. A large number of existing studies have shown that even after surgical treatment, women with …

  • 140 views
  • 17 Sep, 2021
  • 1 location
Phase Ib/II Trial of Copanlisib in Combination With Trastuzumab and Pertuzumab After Induction Treatment of HER2 Positive (HER2+) Metastatic Breast Cancer (MBC) With PIK3CA Mutation or PTEN Mutation

This phase Ib/II trial studies the side effects and best dose of copanlisib when given together with trastuzumab and pertuzumab and to see how well they work after induction treatment in treating patients with HER2 positive stage IV breast cancer with PIK3CA or PTEN mutation. Copanlisib may stop the growth …

neutrophil count
warfarin
hormone therapy
ejection fraction
targeted therapy
  • 1 views
  • 21 Oct, 2022
  • 2 locations
RESET-medication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma (RESET-m)

Depression is a recurrent debilitating psychiatric disorder with a lifetime prevalence of 20%. Even though antidepressants and psychotherapy are often effective, a substantial proportion of patients does not respond to currently used evidence-based treatments. The heterogeneous nature of depressive symptoms is a major obstacle for the development of novel effective …

  • 0 views
  • 27 Apr, 2022
  • 1 location
Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. (TRIFOUR)

Triple negative breast cancer (TNBC) represents approximately 15% of all breast cancers (BC) worldwide. The term triple negative means that tumor growth is not stimulated by the hormones estrogen and progesterone, nor by the HER2 protein, so unlike other types of BC, TNBC, which is an aggressive form of BC, …

erbb2
HER2
triple negative breast cancer
estrogen
carboplatin
  • 0 views
  • 16 Mar, 2022
  • 8 locations
Inflammatory Breast Cancer and Tumor Markers

, progesterone receptor, the p53 gene, and others) and angiogenesis parameters (such as various proteins involved in vessel formation) will be examined to determine their prevalence in tissue specimens

progesterone receptor
estrogen receptor
estrogen
inflammatory breast cancer
progesterone
  • 4 views
  • 07 Nov, 2020
  • 1 location
Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive

correlates with the estrogen/progesterone receptor positive (ER+/PR+) pattern. On the other hand, these patients frequently present with clinical signs of a hyperestrogenism (chronic anovulation, infertility

cancer
progestin
laparoscopy
estrogen
lymphadenectomy
  • 197 views
  • 28 Feb, 2022
  • 18 locations
Retrospective Observational Study With Real-World Data to Assess Demographic and Clinicopathological Profiles, and Management of Breast Cancer Patients With Positive, Low or Negative Expression of HER2 in Spain (RosHER)

This is a data-driven, retrospective, longitudinal, population- based, observational, multi-centered study using secondary data captured from congruent electronic health records (EHRs).

  • 0 views
  • 25 Oct, 2022
  • 5 locations